重度精神障碍患者AMPA受体正电子发射断层显像特征分析
本研究使用[11C]K-2 AMPA受体PET示踪剂,对149例精神障碍患者(精神分裂症42例、双相障碍37例、抑郁35例、孤独症谱系障碍35例)和70名健康对照进行脑内AMPA受体密度测定。研究发现各疾病中AMPA受体密度与症状评分相关的脑区,以及患者与健康对照间密度显著差异的脑区,部分脑区跨疾病共同受累,且四种疾病各具独特的AMPA受体分布模式。
要点
- 研究纳入149例精神障碍患者与70名健康对照,用[11C]K-2 PET测定脑内AMPA受体密度。
- 各疾病中检出AMPA受体密度与症状评分相关的脑区,以及患者与对照间密度显著差异的脑区。
- 部分差异脑区跨疾病共同出现,提示精神障碍共有的受累区域;四种疾病各有独特AMPA受体分布模式。
核心结论
- 精神分裂症、双相障碍、抑郁和孤独症谱系障碍各以独特的AMPA受体分布模式为特征。
- 基于[11C]K-2的精神障碍研究方法有助于阐明跨疾病的生物学机制,并为基于突触生理学开发新型诊断和治疗手段开辟道路。
研究设计与样本
- 研究纳入149例精神障碍患者(精神分裂症42例、双相障碍37例、抑郁35例、孤独症谱系障碍35例)和70名健康参与者。
- 所有受试者接受[11C]K-2 PET扫描以测定AMPA受体密度。
主要发现
- 在四种疾病各自中检出AMPA受体密度与症状严重程度评分相关的脑区。
- 检出各精神障碍患者与健康参与者之间AMPA受体密度存在显著差异的脑区。
- 部分差异脑区跨疾病出现,提示为贯穿精神障碍的共同受累区域。
- 精神分裂症、双相障碍、抑郁和孤独症谱系障碍各以独特的AMPA受体分布模式为特征。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Synaptic phenotypes in living patients with psychiatric disorders are poorly characterized. Excitatory glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) is a fundamental component for neurotransmission. We recently developed a positron emission tomography (PET) tracer for AMPAR, [11C]K-2, the first technology to visualize and quantify AMPARs density in living human brain. In this study, we characterized patients with major psychiatric disorders with [11C]K-2. One hundred forty-nine patients with psychiatric disorders (schizophrenia, n = 42; bipolar disorder, n = 37; depression, n = 35; and autism spectrum disorder, n = 35) and 70 healthy participants underwent a PET scan with [11C]K-2 for measurement of AMPAR density. We detected brain regions that showed correlation between AMPAR density and symptomatology scores in each of four disorders. We also found brain areas with significant differences in AMPAR density between patients with each psychiatric disorder and healthy participants. Some of these areas were observed across diseases, indicating that these are commonly affected areas throughout psychiatric disorders. Schizophrenia, bipolar disorder, depression, and autism spectrum disorder are uniquely characterized by AMPAR distribution patterns. Our approach to psychiatric disorders using [11C]K-2 can elucidate the biological mechanisms across diseases and pave the way to develop novel diagnostics and therapeutics based on the synapse physiology.
引用
- Hatano M, Nakajima W, Tani H, et al. Characterization of patients with major psychiatric disorders with AMPA receptor positron emission tomography. Mol Psychiatry. 2024. PMID: 39406998. doi:10.1038/s41380-024-02785-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。